Details about Gisselle Gallego

Access statistics for papers by Gisselle Gallego.

Last updated 2023-11-09. Update your information in the RePEc Author Service.

Short-id: pga336

Working Papers

2010

1. Reducing the use of ineffective health care interventions. CHERE Working Paper 2010/5
   Working Papers, CHERE, University of Technology, Sydney View citations (1)

2009

2. Evidence for funding, organising and delivering health care services targeting secondary prevention and management of chronic conditions. CHERE Working Paper 2009/6
   Working Papers, CHERE, University of Technology, Sydney
3. Framework for the cost benefit analysis of the NSW Department of Community Services Brighter Futures Program. CHERE Working Paper 2009/4
   Working Papers, CHERE, University of Technology, Sydney

2008

4. A model for best practice HTA
   Working Papers, CHERE, University of Technology, Sydney
5. Equity weights for economic evaluation: An Australian Discrete Choice Experiment, CHERE Working Paper 2008/5
   Working Papers, CHERE, University of Technology, Sydney View citations (2)

2007

6. Incorporating economic evidence into cancer care: searching for the missing link
   Working Papers, CHERE, University of Technology, Sydney View citations (1)

Journal Articles

2021

1. Hepatitis B and Liver Cancer: Community Awareness, Knowledge and Beliefs of Middle Eastern Migrants in Sydney, Australia
   IJERPH, 2021, 18, (16), 1-11

2012

2. Chemotherapy Administration
   PharmacoEconomics, 2012, 30, (12), 1173-1186
   Also in PharmacoEconomics, 2012, 30, (12), 1173-1186 (2012) View citations (2)

2011

3. Introduction and uptake of new medical technologies in the Australian health care system: A qualitative study
   Health Policy, 2011, 102, (2), 152-158 View citations (2)

2009

4. Funding and access to high cost medicines in public hospitals in Australia: Decision-makers' perspectives
   Health Policy, 2009, 92, (1), 27-34 View citations (3)

2007

5. Economic Evidence at the Local Level
   PharmacoEconomics, 2007, 25, (12), 1055-1062 View citations (2)
6. Priority setting for high cost medications (HCMs) in public hospitals in Australia: A case study
   Health Policy, 2007, 84, (1), 58-66 View citations (12)